Ergomed acquires ILEX UK office

Ergomed Clinical Research, a pan-European contract research organisation headquartered in Frankfurt, has acquired through a subsidiary the operating assets of ILEX Oncology Inc's clinical research and regulatory service office in Guildford in the UK.

The office was previously owned and operated by ILEX Services, a subsidiary of ILEX Oncology Services, Inc.

Ergomed will become a preferred provider of services to ILEX and will continue to provide site management, monitoring and project management services for ongoing clinical studies outside the US.

US-based ILEX, which is headquartered in San Antonio, Texas, previously maintained the office in Guildford to provide clinical and regulatory services in connection with its rest-of-world development programme. The Guildford office operating assets and employees were transferred to Ergomed's subsidiary, which will provide Campath/Mabcampath international market authorisation services and project management of ongoing trials.

'Given Ergomed's extensive presence in Europe and growing operational activity in the UK, we are excited to establish an operational hub in the UK,' said Ergomed ceo Dr Miroslav Reljanovic. 'We look forward to continuing to assist ILEX with the development of its products in a variety of settings.'